Latest news with #GuriAdemi
Associated Press
3 days ago
- Business
- Associated Press
Shareholder Alert: The Ademi Firm Investigates Whether Sitio Royalties Corp. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Jun 3, 2025-- The Ademi Firm is investigating Sitio (NYSE: STR) for possible breaches of fiduciary duty and other violations of law in its transaction with Viper Energy . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Sitio will receive 0.4855 shares of Class A common stock of a new holding company ('pro forma Viper') for each share of Sitio Class A common stock, and 0.4855 units of Viper's operating subsidiary, Viper Energy Partners LLC, for each unit of Sitio's operating subsidiary (along with a corresponding amount of Class B common stock of pro forma Viper for each share of Sitio Class C common stock), representing an implied value to each Sitio stockholder of $19.41 per share based on the closing price of Viper common stock on June 2, 2025. Sitio insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Sitio by imposing a significant penalty if Sitio accepts a competing bid. We are investigating the conduct of the Sitio board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on CONTACT: Ademi & Fruchter LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 06/03/2025 07:41 AM/DISC: 06/03/2025 07:40 AM
Associated Press
15-05-2025
- Business
- Associated Press
Shareholder Alert: The Ademi Firm investigates whether Foot Locker, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--May 15, 2025-- The Ademi Firm is investigating Foot Locker (NYSE: FL) for possible breaches of fiduciary duty and other violations of law in its transaction with DICK'S Sporting Goods . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Foot Locker will receive either (i) $24.00 in cash or (ii) 0.1168 shares of DICK'S Sporting Goods common stock for each share of Foot Locker common stock. Foot Locker insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Foot Locker by imposing a significant penalty if Foot Locker accepts a competing bid. We are investigating the conduct of the Foot Locker board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on CONTACT: Ademi & Fruchter LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 05/15/2025 08:15 AM/DISC: 05/15/2025 08:16 AM
Associated Press
30-04-2025
- Business
- Associated Press
Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Apr 30, 2025-- The Ademi Firm is investigating Regulus (Nasdaq: RGLS) for possible breaches of fiduciary duty and other violations of law in its transaction with Novartis . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Regulus will receive only $7.00 per share in cash at closing, or $0.8 billion. In addition, Regulus shareholders will receive a contingent value right (CVR) providing for payment of $7.00 per share, contingent upon the achievement of a milestone with respect to regulatory approval of Regulus' lead product candidate, farabursen. Regulus insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Regulus by imposing a significant penalty if Regulus accepts a competing bid. We are investigating the conduct of the Regulus board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on CONTACT: Ademi & Fruchter LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 04/30/2025 07:41 AM/DISC: 04/30/2025 07:41 AM
Associated Press
24-03-2025
- Business
- Associated Press
Shareholder Alert: The Ademi Firm investigates whether Dun & Bradstreet Holdings, Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Dun & Bradstreet (NYSE: DNB) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearlake . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Dun & Bradstreet shareholders will receive only $9.15 in cash for each share of common stock they own, with an equity value of $4.1 billion. Dun & Bradstreet insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Dun & Bradstreet by imposing a significant penalty if Dun & Bradstreet accepts a competing bid. We are investigating the conduct of the Dun & Bradstreet board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Guri Ademi Toll Free: (866) 264-3995 SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 03/24/2025 10:05 AM/DISC: 03/24/2025 10:05 AM
Associated Press
24-03-2025
- Business
- Associated Press
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders
The Ademi Firm is investigating LENSAR (NASDAQ: LNSR) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, LENSAR shareholders will receive only $14.00 per share in cash (an aggregate implied value of approximately $356 million*), with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR's products between January 1, 2026, and December 31, 2027. LENSAR insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for LENSAR by imposing a significant penalty if LENSAR accepts a competing bid. We are investigating the conduct of the LENSAR board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Guri Ademi Toll Free: (866) 264-3995 SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 03/24/2025 09:46 AM/DISC: 03/24/2025 09:47 AM
